1. O’Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry 1996;8:37-54.
2. Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry 1998;59(suppl 2):53-61.
3. O’Hara MW. Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 1986;43:569-73.
4. Beck CT. Predictors of postpartum depression: an update. Nursing Res 2001;50(5):275-85.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision. Washington, DC, American Psychiatric Association, 2000.
6. Evins GG, Theofrastous JP, Galvin SL. Postpartum depression: a comparison of screening and routine clinical evaluation. Am J Obstet Gynecol 2000;182(5):1080-2.
7. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10 –item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-6.
8. Beck CT, Gable RK. Further validation of the postpartum depression screening scale. Nursing Res 2001;50(3):155-64.
9. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997;314(7085):932-6.
10. Stuart S, O’Hara MW. Interpersonal psychotherapy for postpartum depression: a treatment program. J Psychother Pract Res 1995;4:18-29.
11. O’Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000;57(11):1039-45.
12. Misri S, Kostaras X, Fox D, Kostaras D. The impact of partner support in the treatment of postpartum depression. Can J Psychiatry 2000;45(6):554-8.
13. Burt VK, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158(7):1001-9.
14. Birnbaum CS, Cohen LS, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series (electronic article). Pediatrics 1999;104(1):www.pediatrics.org/cgi/content/full/104/1/e11
15. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32(6):1253-5.
16. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine (electronic article). Pediatrics 1999;104(5):http://www.pediatrics.org/cgi/content/full/104/5/e61
17. Epperson CN, Anderson GM, McDougle CJ. Sertraline and breast feeding (letter). N Engl J Med 1997;336(16):1189-90.
18. Wisner KL, Perel JM, Blumer J. Serum sertraline and n-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998;155(5):690-2.
19. Epperson N, Czarkowski KA, Ward-O’Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158(10):1631-7.
20. Misri S, Kim J, Riggs KW, Kostaras X. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000;61(11):828-32.
21. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk (letter). Br J Clin Pharmacol 1991;31:209.-
22. Piontek CM, Wisner KL, Perel JM, Peindl KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001;62(2):111-3.
23. Wisner KL, Perel JM, Foglia JP. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry 1995;56(1):17-20.
24. Altshuler LL, Burt VK, McMullen M, Hendrick V. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995;56(6):243-5.
25. Briggs GG, Samson JH, Ambrose PJ, Schroeder DH. Excretion of bupropion in breast milk. Ann Pharmacother 1993;27(4):431-3.
26. Verbeeck RK, Ross SG, McKenna EA. Excretion of trazodone in breast milk. Br J Clin Pharmacol 1986;22:367-70.
27. Yapp P, Ilett KF, Kristensen JH, et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 2000;34(11):1269-72.
28. Illett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998;45:459-62.
29. Hill RC, McIvor RJ, Wojnar-Horton RE, et al. Risperidone distribution and excretion in human milk: case report and estimated infant exposure during breast-feeding (letter). J Clin Psychopharmacol 2000;20(2):285-6.
30. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiat 1994;45:444-50.